SEC-registered equity research. Ratings, targets & stops on 100+ US stocks. Get the free Cestrian Daily Market Review by email — no paywall. Link below.
Joined June 2019
- Tweets15.7K
- Following365
- Followers9.7K
- Likes8K
Pinned Tweet
Thanks for featuring our work @StockJabber @BullpenDotNews !
Cestrian Capital Research, Inc retweeted
Investing with the Business Cycle outperforms the market - at lower volatility - and with way less drawdowns.
Our proprietary Business Cycle Allocation Model employs a systematic, non-discretionary investment process, dynamically rotating capital across asset classes and industry sectors based on predefined rules linked to the four phases of the business cycle.
Soon you can invest directly into this model.
I dare to say it is ground-breaking for how to allocate funds. Not on diversification. But fully on the basis of macro developments in each Business Cycle Phase - real time!
This is also why I will call the coming Recession - real time - in the first month of it - to illustrate that not only is it possible. It is mandatory for any Fund manager to be able to do so.
Get to know more - and sign-up on the waiting list HERE: norrmacro.com/investments
More information coming out soon!
Cestrian Capital Research, Inc retweeted
Time to learn about IV folks and how buying calls when the VIX is flying is not a simple game. You might find the stock higher and those calls lower if not careful.
Cestrian Capital Research, Inc retweeted
$XBI
Like Biotech as a sector here. Retesting the 4hr demand zone and 100dma after the breakout. Some March call flow coming in just now
I'm long
Cestrian Capital Research, Inc retweeted
This guy is one of the very few smart macro acc here worth following. All he’s trying to say is when everyone expects a trouble it doesn’t usually happen. For retail to be the exit liquidity a blow off top is needed, they need to take you to the top then rug pull
We are about to see a massive take-off in Risk Assets.
Just when everybody is Fearful 😉
Nasdaq will soar. Same will small caps.
And so will Crypto. Crypto Altseason!
Massive bottom - and the rally will be driven by (the expected) decline in DXY and Bomd yields.
Coming 2-3 months will be extremely Bullish.
Bears will capitulate and Bulls will grow arrogant- right into the REAL TOP!
Now sit back. Get the popcorn out.
And watch the market play with investors emotions 😉
Cestrian Capital Research, Inc retweeted
The market will eventually go up again and we’ll all be talking about October 2026 the same way we talk about all of the other dips since 2022.
Unless this is really the multi year macro top and we’re about to drop 50%+, which I don’t believe to be true.
Go outside and relax, touch grass so they say.
Cestrian Capital Research, Inc retweeted
Readers' pick yesterday, $NVO: Cestrian Capital Research argued Novo Nordisk has not committed to hair loss.
cestriancapitalresearch.com/…
ALT Readers' pick yesterday, $NVO: Cestrian Capital Research argued Novo Nordisk has not committed to hair loss.
Cestrian Capital Research, Inc retweeted
Daily recap: 50 new stock ideas.
1. Steve Eisman on TSLA
2. Best Anchor Stocks on MEDP
3. Convequity on NVDA
4. Cestrian Capital Research on TXN
5. Net Interest on CRWV
6. Convequity on AMZN
See the full daily recap here: bullpen.news/recap/2026-10-2…
Cestrian Capital Research, Inc retweeted
Daily recap: 65 new stock ideas.
1. Sleep Well Investments on ASML
2. Shallow Dives on CBRS
3. Hidden Gems Investing on DAKT
4. Cestrian Capital Research on MSFT
5. Chris Camillo on AMZN
6. Brian McGough on CVNA
See the full daily recap here: bullpen.news/recap/2026-10-2…
Cestrian Capital Research, Inc retweeted
Yesterday's most-read pitch:
cestriancapitalresearch.com/…
ALT Yesterday's most-read pitch:
In July, $INTC management said gross margins would stay comfortably in the 40s. The Q4 guide says 38.0%, down from 44.1% in Q3. Non-GAAP EPS guide $0.25 vs consensus of $0.43-0.44. (Long INTC in Cestrian staff personal accounts.)
Full analysis covers the capex plan, the $23bn equity raise, the cash flow math, and what to watch on 14A customer commitments: cestriancapitalresearch.com/…
When you think of Cestrian, you don’t think “biotech"
But you should
Just ask @BullpenDotNews
Whether you’re a moving-averagista or a Fibonnaci fanboi, you can look at this chart and decide … boolish reversal coming.
$QQQ
I’m long the Nasdaq.
Cestrian Capital Research, Inc retweeted
Part of today's selling is the calendar.
Many US mutual funds close their tax year on 31 October, so today is their last trading day to book losses.
Anyone who bought chips near the summer highs is sitting on a loss worth harvesting. $XLK $QQQ
The Tech sector ETF $XLK is down nearly 5% on the day as the month of October comes to an end. Some of the intraday moves we're seeing look forced...
$INTC gave back 21% post-market on the Q4 guide. Same print: Data Center & AI up 78% to $7.3bn, Foundry loss narrowed to $1.9bn, net cash $3.9bn. The guide was bad. The quarter was not. (Long INTC in Cestrian staff personal accounts.)
The full note walks every segment (Products, Foundry, DCAI, Client), the margin bridge, and Q4 guidance against consensus: cestriancapitalresearch.com/…
Cestrian Capital Research, Inc retweeted
Daily recap: 86 new stock ideas.
1. Cestrian Capital Research on INTC
2. Passage Research on NVDA
3. junkbondinvestor on MSFT
4. The Undercovered Dozen on MU
See the full daily recap here: bullpen.news/recap/2026-10-2…
